Chemotherapie beim harnblasenkarzinom: Update 2012: Aus AUO (Arbeitsgemeinschaft Urologische Onkologie) und IABC (Interdisziplinäre Arbeitsgruppe Blasencarcinom)

M. M. Heck; J. E. Gschwend; M. Retz

doi:10.1007/s00120-012-2822-9

Chemotherapie beim harnblasenkarzinom: Update 2012: Aus AUO (Arbeitsgemeinschaft Urologische Onkologie) und IABC (Interdisziplinäre Arbeitsgruppe Blasencarcinom)

Translated title of the contribution: Chemotherapy for bladder cancer: 2012 Update. From AUO (" Arbeitsgemeinschaft Urologische Onkologie") and IABC (" Interdisziplinäre Arbeitsgruppe Blasencarcinom")

M. M. Heck
, J. E. Gschwend
, M. Retz

Technical University of Munich

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Abstract

This article summarizes contemporary standards in systemic therapy for urothelial carcinoma as well as updated results of peer-reviewed publications and international bladder cancer meetings in 2011. Both neoadjuvant and adjuvant trials for locally advanced carcinoma and data on systemic chemotherapy for metastatic bladder cancer are discussed.

Translated title of the contribution	Chemotherapy for bladder cancer: 2012 Update. From AUO (" Arbeitsgemeinschaft Urologische Onkologie") and IABC (" Interdisziplinäre Arbeitsgruppe Blasencarcinom")
Original language	German
Pages (from-to)	829-836
Number of pages	8
Journal	Urologe - Ausgabe A
Volume	51
Issue number	6
DOIs	https://doi.org/10.1007/s00120-012-2822-9
State	Published - Jun 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/s00120-012-2822-9

Cite this

@article{8e3ddfc644434b3198d94b640bcc1ceb,

title = "Chemotherapie beim harnblasenkarzinom: Update 2012: Aus AUO (Arbeitsgemeinschaft Urologische Onkologie) und IABC (Interdisziplin{\"a}re Arbeitsgruppe Blasencarcinom)",

abstract = "This article summarizes contemporary standards in systemic therapy for urothelial carcinoma as well as updated results of peer-reviewed publications and international bladder cancer meetings in 2011. Both neoadjuvant and adjuvant trials for locally advanced carcinoma and data on systemic chemotherapy for metastatic bladder cancer are discussed.",

keywords = "Adjuvant chemotherapy, Bladder cancer, Neoadjuvant chemotherapy, Systemic chemotherapy, Urothelial carcinoma",

author = "Heck, \{M. M.\} and Gschwend, \{J. E.\} and M. Retz",

year = "2012",

month = jun,

doi = "10.1007/s00120-012-2822-9",

language = "Deutsch",

volume = "51",

pages = "829--836",

journal = "Urologe - Ausgabe A",

issn = "0340-2592",

publisher = "Springer Medizin",

number = "6",

}

TY - JOUR

T1 - Chemotherapie beim harnblasenkarzinom

T2 - Update 2012: Aus AUO (Arbeitsgemeinschaft Urologische Onkologie) und IABC (Interdisziplinäre Arbeitsgruppe Blasencarcinom)

AU - Heck, M. M.

AU - Gschwend, J. E.

AU - Retz, M.

PY - 2012/6

Y1 - 2012/6

N2 - This article summarizes contemporary standards in systemic therapy for urothelial carcinoma as well as updated results of peer-reviewed publications and international bladder cancer meetings in 2011. Both neoadjuvant and adjuvant trials for locally advanced carcinoma and data on systemic chemotherapy for metastatic bladder cancer are discussed.

AB - This article summarizes contemporary standards in systemic therapy for urothelial carcinoma as well as updated results of peer-reviewed publications and international bladder cancer meetings in 2011. Both neoadjuvant and adjuvant trials for locally advanced carcinoma and data on systemic chemotherapy for metastatic bladder cancer are discussed.

KW - Adjuvant chemotherapy

KW - Bladder cancer

KW - Neoadjuvant chemotherapy

KW - Systemic chemotherapy

KW - Urothelial carcinoma

UR - https://www.scopus.com/pages/publications/84864150045

U2 - 10.1007/s00120-012-2822-9

DO - 10.1007/s00120-012-2822-9

M3 - Übersichtsartikel

C2 - 22526172

AN - SCOPUS:84864150045

SN - 0340-2592

VL - 51

SP - 829

EP - 836

JO - Urologe - Ausgabe A

JF - Urologe - Ausgabe A

IS - 6

ER -

Chemotherapie beim harnblasenkarzinom: Update 2012: Aus AUO (Arbeitsgemeinschaft Urologische Onkologie) und IABC (Interdisziplinäre Arbeitsgruppe Blasencarcinom)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this